Raines William F III

SEC source: 0001437749-26-012586 · rdgdoc.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,676

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.

SEC source: 0001437749-25-017869 · rdgdoc.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,104

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors.

SEC source: 0001437749-24-028129 · rdgdoc.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,256

F1 · security: Pursuant to the Settlement, Purchase and Release Agreement dated August 23, 2024, entered into between the Issuer, CBD Industries, LLC and Majik Medicine, LLC ("Majik"), the Reporting Person was appointed as the true and lawful attorney, agent and proxy, with full power of substitution, for Majik for the issuance of 75,000 shares for 12 months from the Transaction Date (the "Proxy Period"). During the Proxy Period, the Reporting Person is entitled to (i) vote the shares at all shareholder meetings of the Issuer, (ii) execute instruments, consents, directions or other documents relative to the corporate affairs of the Issuer, (iii) calling for the approval or disapproval of any corporate act or transaction by the shareholders of the Issuer, and (iv) vote or otherwise act, upon any and all matters and questions relating to the Issuer. The Reporting Person shall vote in accordance with the recommendation of a majority of the independent members of the Issuer's Board of Directors.

SEC source: 0001437749-24-010749 · rdgdoc.xml · derivative · entry 2

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2029-03-29

F2 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested.

F3 · price: Not applicable.

SEC source: 0001437749-24-010749 · rdgdoc.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,256

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2024, September 30, 2024, December 31, 2024 and March 31, 2025. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024.

SEC source: 0001437749-23-004162 · rdgdoc.xml · derivative · entry 3

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-02-17

F3 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested.

F4 · price: Not applicable.

SEC source: 0001437749-23-004162 · rdgdoc.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,342

F1 · security: The restricted shares of common stock were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted shares of common stock vest quarterly in equal increments on June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024, subject to continued service as a director of the Issuer on each applicable vesting date.

SEC source: 0001654954-22-005147 · section16.xml · derivative · entry 3

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2027-03-11

F3 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The stock options are fully vested.

F4 · price: Not applicable.

SEC source: 0001654954-22-005147 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,342

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The restricted stock units vest quarterly in equal increments on June 30, 2022, September 30, 2022, December 31, 2022 and March 31, 2023, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 6

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: common stock · 30,000 shares

Expires 2026-03-11

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 5

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2022-03-12

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 4

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-12-31

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 3

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-09-30

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · derivative · entry 2

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250

Underlying: common stock · 1,250 shares

Expires 2021-06-30

F3 · shares: The Reporting Person is a member of the Issuer's Board of Directors. The acquisitions by the Reporting Person reported in this Form 4 represent grants to the Reporting Person by the Issuer under its 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002847 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,775,924

F1 · shares: Under the terms of the Agreement and Plan of Merger dated December 3, 2018 (the "Merger Agreement") and the related Voting Proxy dated December 20, 2018 (the "Voting Proxy"), the independent Chairman of the Audit Committee of the Issuer's Board of Directors held voting rights over an aggregate of 8,750,000 shares of common stock (the "Second Tranche Shares") initially issued to CBD Holding, LLC ("CBDH") until the unrestricted voting rights to those shares vest pursuant to the terms of the Merger Agreement. On December 20, 2019 the unrestricted voting rights to the first 2,187,500 shares vested. On February 26, 2020, in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement, the CBDH members entered into similar Voting Proxy agreements with the Issuer. Until the unrestricted voting rights vest, Mr. Raines, as independent Chairman of the Audit Committee of the Issuer's Board of Directors, holds voting rights over these shares and will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of the Issuer's Board of Directors. The Voting Proxy does not prohibit the shareholder from disposing of any portion of the Second Tranche Shares for which unrestricted voting rights have not yet vested. The dispositions by the Reporting Person reported in this Form 4 represents Second Tranche Shares which were subject to the Voting Proxy that were held by non-affiliates of the Issuer for which Rule 144 legend removals were requested and processed and, accordingly, are no longer subject to Voting Proxy agreements.

F2 · ownership.nature: The number of shares of common stock beneficially owned by the Reporting Person includes (i) 1,342 shares held by him directly; (ii) 92,582 shares held of record by Board Investor Group II, LLC; and (iii) 3,682,000 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 3,682,000 Second Tranche Shares which are subject to the Voting Proxy agreements. See footnote 1.

SEC source: 0001654954-21-010802 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,342

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

SEC source: 0001654954-21-002293 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,342

SEC source: 0001654954-20-013847 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 4,488,924

F1 · ownership.nature: Under the terms of the Agreement and Plan of Merger dated December 3, 2018 (the "Merger Agreement") and the related Voting Proxy dated December 20, 2018 (the "Voting Proxy"), the independent Chairman of the Audit Committee of the Issuer's Board of Directors held voting rights over an aggregate of 8,750,000 shares of common stock (the "Second Tranche Shares") initially issued to CBD Holding, LLC ("CBDH") until the unrestricted voting rights to those shares vest pursuant to the terms of the Merger Agreement. On December 20, 2019 the unrestricted voting rights to the first 2,187,500 shares vested. On February 26, 2020, in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement (the "CBDH Distribution Agreement"), CBDH distributed the Second Tranche Shares to its members on a pro rata basis. On February 26, 2020, in connection with the CBDH Distribution Agreement, the CBDH members entered into similar Voting Proxy Agreements with the Issuer. On December 20, 2020 the unrestricted voting rights to an additional 2,187,5000 Second Tranche Shares vested pursuant to the terms of the Merger Agreement. The unrestricted voting rights to the remaining4,375,000 Second Tranche Shares will vest as follows: (i) 2,187,500 shares will vest on June 20, 2022; and (ii) the remaining 2,187,500 shares will vest on December 20, 2023. Until the unrestricted voting rights vest, Mr. Raines, as independent Chairman of the Audit Committee of the Issuer's Board of Directors, holds voting rights over these shares and will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of the Issuer's Board of Directors. Mr. Raines disclaims beneficial ownership of the securities held of record by the CBDH members.

F2 · ownership.nature: The number of shares of common stock beneficially owned by Mr. Raines includes (i) 21,342 shares held by him directly; (ii) 92,582 shares held of record by Board Investor Group II, LLC; and (iii) 4,375,000 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 4,375,000 Second Tranche Shares which are subject to the Voting Proxy Agreements. See footnote 1.

SEC source: 0001654954-20-006041 · section16.xml · derivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-05-27

SEC source: 0001654954-20-004413 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,676,424

F1 · ownership.nature: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated December 3, 2018 by and between the Issuer, its wholly owned subsidiaries, and Cure Based Development, LLC which closed on December 20, 2018 (the "Closing Date"), an aggregate of 8,750,000 shares of the Issuer's common stock (the "Second Tranche Shares") were issued to CBD Holding, LLC ("CBDH") in April 2019 as partial consideration under the terms of the Merger Agreement. Under the terms of the Merger Agreement the Second Tranche Shares were subject to a Voting Proxy Agreement pending the vesting of unrestricted voting rights, of which unrestricted voting rights to an aggregate of 2,187,500 shares vested on December 20, 2019. Pursuant to the Voting Proxy Agreement, the voting rights to the shares of the Issuer's common stock for which unrestricted voting rights have not yet vested are held by the independent chairman of the Audit Committee of the Issuer's board of directors who will vote such shares on any matter brought before the Issuer's shareholders in accordance with the recommendation of its board of directors. On February 26, 2020 in connection with its dissolution and liquidation and pursuant to the terms of a Distribution Agreement (the "CBDH Distribution Agreement"), CBDH distributed the Second Tranche Shares to its members on a pro rata basis. On February 26, 2020, in connection with the CBDH Distribution Agreement, the CBDH members entered into similar Voting Proxy Agreements with the Issuer. On April 23, 2020 the Reporting Person was elected chairman of the Audit Committee of the Issuer's board of directors and currently serves as the proxy holder under the Voting Proxy Agreements. The Reporting Person disclaims beneficial ownership of such securities.

F2 · ownership.nature: The number of shares of common stock beneficially owned by Mr. Raines includes (i) 21,342 shares held by him directly; (ii) 92,582 shares held of record by Board Investor Group II, LLC; and (iii) 6,562,500 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 6,562,500 Second Tranche Shares which are subject to the Voting Proxy Agreements. See footnote 1.

SEC source: 0001654954-20-000510 · section16.xml · nonDerivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 113,924

F1 · ownership.direct: The number of shares acquired by Mr. Raines as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Raines after giving effect to this acquisition includes (i) 21,342 shares held by him directly, and (ii) 92,582 shares held of record by Board Investor Group II, LLC. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The number of shares acquired by Mr. Raines as reported in this Form 4 were purchased by him individually. The number of shares of common stock beneficially owned by Mr. Raines after giving effect to this acquisition includes (i) 21,342 shares held by him directly, and (ii) 92,582 shares held of record by Board Investor Group II, LLC. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001654954-19-009616 · section16.xml · derivative · entry 1

Raines William F III · CIK 0001773698 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common stock · 20,000 shares

Expires 2029-08-14